Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Precision medicine selection with MyPathway for solid tumours

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
Precision medicine selection with MyPathway for solid tumours ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
4 Jun 2016

Liquid biopsy may help guide treatment decisions for advanced solid tumours

Prof Philip Mack - University of California Davis, Davis, USA
Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )
4 Jun 2016

ASCO 2016: Expert discussion on the latest on multiple myeloma

Dr Sagar Lonial and Dr Paul Richardson
ASCO 2016: Expert discussion on the latest on multiple myeloma ( Dr Sagar Lonial and Dr Paul Richardson )
3 Jun 2016

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin

Dr Hope Rugo - University of California, San Francisco, USA
Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )
3 Jun 2016

Hypo-fractionation of prostate cancer radiotherapy

Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada
Hypo-fractionation of prostate cancer radiotherapy ( Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada )
3 Jun 2016

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK
Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma ( Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK )
3 Jun 2016

Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin

Dr Hope Rugo - University of California, San Francisco, USA
Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )
3 Jun 2016

Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada
Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer ( Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada )
3 Jun 2016

Temozolomide after radiotherapy improves glioma survival

Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands
Temozolomide after radiotherapy improves glioma survival ( Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )
3 Jun 2016

Mechanistic studies of DNA repair

Tomas Lindahl - Nobel Prize for Chemistry 2015
Mechanistic studies of DNA repair ( Tomas Lindahl - Nobel Prize for Chemistry 2015 )
13 May 2016

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi
Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )
6 May 2016

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
6 May 2016